1-(4,7-dimethylquinazolin-2-yl)-3-(2-methoxyethyl)guanidine

ID: ALA5221018

PubChem CID: 168298414

Max Phase: Preclinical

Molecular Formula: C14H19N5O

Molecular Weight: 273.34

This compound is available for customization.

Associated Items:

Names and Identifiers

Canonical SMILES:  COCCNC(=N)Nc1nc(C)c2ccc(C)cc2n1

Standard InChI:  InChI=1S/C14H19N5O/c1-9-4-5-11-10(2)17-14(18-12(11)8-9)19-13(15)16-6-7-20-3/h4-5,8H,6-7H2,1-3H3,(H3,15,16,17,18,19)

Standard InChI Key:  HNEMHMXFZLCGSK-UHFFFAOYSA-N

Molfile:  

 
     RDKit          2D

 20 21  0  0  0  0  0  0  0  0999 V2000
    0.7131    0.0052    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.7131   -0.8197    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.4277   -1.2322    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    2.1421   -0.8197    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.8567   -1.2322    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.5713   -0.8197    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    4.2858   -1.2322    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.0013   -1.2322    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -0.7157   -0.8197    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.7157    0.0010    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -1.4323    0.4134    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.4323    1.2385    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.1449    0.0026    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.1449   -0.8222    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.4273   -1.2363    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -2.8550   -1.2340    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.5713   -0.8260    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.5713    0.0023    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.8568    0.4144    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.2858   -1.2385    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  2  1  2  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  1  0
  8  2  1  0
  9  8  1  0
  9 10  1  0
 10 11  2  0
 11 12  1  0
 13 11  1  0
 14 13  2  0
 14 15  1  0
 15  9  2  0
 16 14  1  0
 17 16  2  0
 18 17  1  0
 19 18  2  0
 13 19  1  0
 17 20  1  0
M  END

Alternative Forms

  1. Parent:

    ALA5221018

    ---

Associated Targets(Human)

Premature termination codon (106 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Topical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 273.34Molecular Weight (Monoisotopic): 273.1590AlogP: 1.83#Rotatable Bonds: 4
Polar Surface Area: 82.92Molecular Species: NEUTRALHBA: 4HBD: 3
#RO5 Violations: HBA (Lipinski): 6HBD (Lipinski): 3#RO5 Violations (Lipinski):
CX Acidic pKa: CX Basic pKa: 7.52CX LogP: 1.95CX LogD: 1.59
Aromatic Rings: 2Heavy Atoms: 20QED Weighted: 0.45Np Likeness Score: -1.42

References

1. Morrill C, Friesen WJ, Babu S, Baiazitov RY, Du W, Karloff DB, Lee CS, Moon YC, Ren H, Sierra J, Tomizawa Y, Vazirani P, Welch EM, Xue X, Zhuo J..  (2022)  Guanidino quinazolines and pyrimidines promote readthrough of premature termination codons in cells with native nonsense mutations.,  76  [PMID:36150638] [10.1016/j.bmcl.2022.128989]

Source